• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[细胞毒性药物血液毒性副作用的发生特征——一家区级医院十年回顾性研究结果]

[Characteristics of the occurrence of hematotoxic side effects of cytostatic drugs--results of a retrospective 10 year study of a district hospital].

作者信息

Radke E U, Papke J, Michel G, Hübler A, Mustafa K, Martin K, Eichelroth E

机构信息

Inneren Abteilung, Kreiskrankenhauses Sebnitz.

出版信息

Z Gesamte Inn Med. 1990 Apr 15;45(8):214-8.

PMID:2378133
Abstract

From 1978 to 1988 in 77 patients of a district hospital, 58 females and 19 males, with malignant tumours or haemoblastoses a therapy with cytostatic agents was finished. A retrospective study analyses characteristics of haematotoxic side effects of cytostatic agents, which despite usual dosage according to the valid guide-lines have appeared in this patient population. According to this the granulocytopoiesis is injured most frequently and most severely. In one third of all patients under influence of cytostatic agents the number of the segment-nuclear granulocytes in the peripheral blood decreased deeper than 0.5 Gpt/l (severe neutropenia). In toxic influences on the thrombopoiesis slight and medium degrees of severity are dominating. Lesions of the erythropoiesis are apparently more infrequent, though they are more difficult to be proved. Further characteristics in the occurrence of severe neutropenias (date, dependence on age, pharmacological aspects) are demonstrated and discussed.

摘要

1978年至1988年期间,某地区医院的77例患者(58名女性和19名男性)完成了针对恶性肿瘤或血液病的细胞毒性药物治疗。一项回顾性研究分析了细胞毒性药物血液毒性副作用的特征,这些副作用在该患者群体中出现,尽管是按照有效指南的常规剂量使用。据此,粒细胞生成最常且最严重地受到损害。在所有接受细胞毒性药物影响的患者中,三分之一外周血中节段核粒细胞数量下降超过0.5 Gpt/l(严重中性粒细胞减少症)。对血小板生成的毒性影响以轻度和中度为主。红细胞生成的损伤显然较少见,尽管更难证实。文中展示并讨论了严重中性粒细胞减少症发生的其他特征(日期、对年龄的依赖性、药理学方面)。

相似文献

1
[Characteristics of the occurrence of hematotoxic side effects of cytostatic drugs--results of a retrospective 10 year study of a district hospital].[细胞毒性药物血液毒性副作用的发生特征——一家区级医院十年回顾性研究结果]
Z Gesamte Inn Med. 1990 Apr 15;45(8):214-8.
2
[Severe neutropenia following cytostatic drug therapy--clinical symptoms, follow-up and prognosis in 26 patients of a district hospital].
Z Gesamte Inn Med. 1990 Apr 15;45(8):219-22.
3
[Pharmacotoxic aspects of antiblastic chemotherapeutic agents in hematological oncology].
Clin Ter. 1979 Nov 30;91(4):339-50.
4
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.异环磷酰胺、卡铂、依托泊苷和紫杉醇化疗:一项剂量递增研究。
Semin Oncol. 1996 Jun;23(3 Suppl 6):74-7.
5
Causes of agranulocytosis in a hospital population: identification of dipyrone as an important causative agent.医院人群中粒细胞缺乏症的病因:确定安乃近为重要致病因素。
Isr J Med Sci. 1983 Mar;19(3):225-9.
6
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.长春瑞滨和顺铂(CIVIC方案)用于含蒽环类和/或紫杉醇方案治疗失败后的转移性乳腺癌治疗。
Cancer. 1998 Jan 1;82(1):134-40.
7
Reduction of chemotherapy-induced neutropenic complications with a short course of lithium carbonate.短期使用碳酸锂减少化疗引起的中性粒细胞减少并发症
Clin Invest Med. 1979;2(1):51-3.
8
Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.卡铂联合紫杉醇治疗妇科恶性肿瘤:克利夫兰诊所的经验。
Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-26-S15-29.
9
[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer].
Orv Hetil. 1994 Dec 18;135(51):2815-9.
10
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.紫杉醇/卡铂联合用药治疗既往接受过治疗的晚期卵巢癌患者的疗效与安全性:一项法国国家卵巢癌研究组多中心II期研究
Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-30-S15-35.